E Merck provides funds for VWR acquisition
This article was originally published in Clinica
In a string of deals last week, German company E Merck raised its stake in US-based VWR, which in turn used the funds to purchase Baxter International's industrial division. The result is a further strengthening of E Merck's interests in laboratory distribution and a concomitant lessening of Baxter's weighting in areas less profitable than its medical specialties business.
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.